Trials / Unknown
UnknownNCT04259112
Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients
Effect of Pneumoperitoneum Pressure and the Extent of Neuromuscular Block on Renal Function in Patients With Diabetes Undergoing Laparoscopic Pelvic Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 648 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
In this single center, double-blind, randomized controlled clinical trial, we will include 648 diabetes patients aged 18-70 undergoing laparoscopic pelvic tumor resection. They will be randomized to the following four groups: high-pressure pneumoperitoneum (10mmHg)+ deep neuromuscular block group, high-pressure pneumoperitoneum (15mmHg)+moderate neuromuscular block group, low-pressure pneumoperitoneum + deep neuromuscular block group and low-pressure pneumoperitoneum+moderate neuromuscular block group. Deep neuromuscular block is defined as post tetanic count (PTC) 1-2, and low neuromuscular block is defined as train-of-four (TOF) twitch 1-2. The outcomes will be indicators for acute kidney injury and surgical condition.
Detailed description
In this single center, double-blind, randomized controlled clinical trial, we will include 648 diabetes patients aged 18-70 undergoing laparoscopic pelvic tumor resection under general anesthesia. They will be randomized to the following four groups: high-pressure pneumoperitoneum (10mmHg)+ deep neuromuscular block group, high-pressure pneumoperitoneum (15mmHg)+moderate neuromuscular block group, low-pressure pneumoperitoneum + deep neuromuscular block group and low-pressure pneumoperitoneum+moderate neuromuscular block group. Neuromuscular block will be induced by rocuronium bolus and maintained by a continuous infusion of rocuronium. Deep neuromuscular block is defined as PTC 1-2, and low neuromuscular block is defined as train-of-four TOF twitch 1-2. The primary outcome will be serum Cystatin C level, and the secondary outcomes will be serum creatine level, urinary sediment, intraoperative urine output, duration of surgery, surgical space condition and occurrence bucking and body movement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | high pressure | High-pressure pneumoperitoneum is defined as intra-abdominal pressure 12-15 mmHg. |
| DRUG | deep neuromuscular block | Deep neuromuscular block is defined as PTC 1-2. |
| PROCEDURE | low pressure | Low-pressure pneumoperitoneum is defined as intra-abdominal pressure 7-10 mmHg. |
| DRUG | moderate neuromuscular block | Moderate neuromuscular block is defined as TOF twitch 1-2. |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2023-10-01
- Completion
- 2023-12-01
- First posted
- 2020-02-06
- Last updated
- 2020-10-06
Source: ClinicalTrials.gov record NCT04259112. Inclusion in this directory is not an endorsement.